Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07315646

Pain Associated wIth traditioNal Versus uLtrasound guidEd iuS (Intra Uterine System) inSertion

Rationale: The 2019 Belgian Health Survey shows that the combined oral contraceptive pill is the most commonly used form of contraception. However, the Pearl index of Long-acting reversible contraceptive (LARC) methods is significantly better (perfect and typical use <0.5) compared to the combined oral contraceptive pill (perfect use <1.0, typical use 2-9). An IUS is an example of a LARC method. IUS insertion might be painful. Because of this, women may be reluctant to opt for an IUS. The traditional technique for an IUS insertion uses a speculum after which a Pozzi tenaculum is placed on the cervix so that the uterus is brought into the stretching position by means of traction. The cavum is then measured by a uterine sound. These actions and the use of these instruments can contribute to the pain experience during insertion. The new technique, transabdominal sonographic (TAS) insertion, could reduce the pain experience during insertion. This new technique uses transabdominal sonography during IUS placement. The placement under constant visualization eliminates the need for Pozzi tenaculum and uterine soundings. Little high quality studies have been conducted on the advantages and disadvantages of the TAS technique as demonstrated by a non-published systematic review of the literature.

Research question/goal: Is the insertion of an IUS (Kyleena/Mirena) using the TAS technique less painful than the traditional technique?

Study design: A randomized trial (RCT) in which the subject is blinded to the insertion technique.

Study population: Women wishing an IUS (Kyleena & Mirena)

Primary and secondary outcomes:

The primary outcomes are the pain during insertion (Numeric Rating Scale (NRS) score 0-10) and dislocation: non-fundal position (> 3mm fundal distance postinsertion) in the uterine cavity (Y/N).

Secondary outcomes include the average and worst pain in the first week after insertion (NRS 0-10), expulsion of the IUS, perforation of the uterine wall, failure of insertion, the occurrence of vagal symptoms, use of pain relief the first 7 days after placement, subject satisfaction about the procedure, successful IUS placement.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ghent University Hospital

Ghent, 9000, Belgium

Location status: Recruiting

Location contact

Clinical Trial Coordinator Clinical Trial Coordinator

CONTACT

[email protected]

+32 09 332 48 72

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women between18 years and 60 years (at the time of signing the ICF)
  • Who wish to have an IUS (Kyleena/Mirena) for reasons of family planning, conservative treatment for abnormal uterine bleeding or as part of hormonal treatment for menopausal symptoms
  • Dutch-speaking subjects

Exclusion criteria

  • History of difficult IUS placement
  • Known cervical stenosis
  • Asherman's syndrome
  • Standard contraindications to an IUS (eg breast cancer, recent deep vein thrombosis, anatomical uterine abnormalities, pregnancy, acute PID, cervicitis, vaginitis or any lower genital tract infection, cervical or endometrial malignancy, history of septic abortion or postpartum endometritis in the last 3 months,.. )
  • Current pelvic inflammatory disease
  • Pregnancy
  • Trophoblastic disease
  • Known cervical or endometrial carcinoma
  • Patients who have the profession of midwife, nurse or doctor.

Treatment and study plan

IUS (intrauterine system) insertion

Procedure

Intra-uterine device insertion (technique based on randomization arm)

Primary outcomes

  1. Pain during insertion of the IUS

    Time frame: From enrollment to the intervention date (IUS placement)

    Pain during insertion, reported by the subject on a Numeric Rating Scale (NRS scale) 0-10

  2. Dislocation

    Time frame: From enrollment to intervention date (IUS placement)

    Dislocation: non-fundal position (> 3mm fundal distance postinsertion) in the uterine cavity (Y/N)

Secondary outcomes

  1. Expulsion

    Time frame: During of directly after the intervention (IUS placement)

    Expulsion of the IUS during the procedure (Y/N)

  2. Failure of insertion

    Time frame: During the procedure of IUS placement

    Failure of insertion (yes/no)

  3. vagal symptoms

    Time frame: During IUD insertion

    Vagal symptoms: paillor, sweating, syncope (yes/no)

  4. Pain experience during 7 days after placement

    Time frame: During the 7 days after IUS insertion

    Pain experience (average and worst pain) during 7 days after placement (NRS 0-10)

  5. Pain relief taken during the 7 days after IUS placement

    Time frame: During the 7 days after IUS placement

    Pain relief taken during the 7 days after placement (Y/N, if yes specify in text field (what, dose, timing))

  6. Satisfaction with the procedure

    Time frame: Seven days after IUS placement

    Subject satisfaction with the technique (5 point Likert scale)

  7. Successful IUS placement

    Time frame: Directly after IUS insertion procedure

    Successful IUS placement (Y/N)

  8. Perforation

    Time frame: During IUS placement

    Perforation: IUS perforates the uterine wall (Y/N). Characterized by sharp pain and blood loss during insertion, ultrasound extrauterine position in total perforation or positioned in the myometrium in partial perforation.

Study contacts

Contact information is provided by the study sponsor or research team.

Margot Van Geyte, MD

CONTACT

[email protected]

+329323044

Study team Gynaecology & Obstetrics UZ Gent

CONTACT

[email protected]

+32 9 332 48 72

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

  • Imelda Hospital, Bonheiden

Registry information

Official study title

The PAINLESS Study: Pain Associated wIth traditioNal Versus uLtrasound guidEd iuS (Intra Uterine System) inSertion

Acronym: PAINLESS

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jan 2, 2026
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.